Skyrocketing Medicine Prices: A Growing Concern for Patients
A bitter pill to swallow: Patients in Malta are facing a harsh reality as medicine prices soar, with some medications seeing price hikes of over 200%. This issue has sparked a heated debate, leaving many wondering why their health comes at such a high cost.
One eye-opening example is Flarex eye drops, which treat eye inflammation. In just a few months, the price skyrocketed from €5.31 to a staggering €17.10. Similarly, Otosporin ear drops, used to combat ear infections, increased from €4.61 to a painful €13.95, a 200% jump.
But it's not just these specialized treatments; popular medications like Buscopan tablets for muscle spasms, Sudocrem for baby skin redness, and Ventolin inhalers for asthma, are also taking a bigger bite out of consumers' wallets. For instance, a 250g tub of Sudocrem cream saw a 72% increase, jumping from €7.34 to €12.65. Buscopan tablets now retail at €19.90, double their previous price. Asthma sufferers are also feeling the pinch, with Ventolin inhalers now costing €7.49, an increase of €4.34 or 137%.
This comprehensive list, independently compiled by a pharmacist over 18 months, includes around 100 medications, ranging from over-the-counter treatments to prescription drugs. The pharmacist, speaking anonymously, shared the data with MaltaToday, and the list was also presented in parliament by Opposition MP Stephen Spiteri.
But here's where it gets controversial... Even pain relievers, a staple in many households, haven't been spared. A box of 20 Parcoten tablets now costs €8.95, an 18% increase. A box of 48 Panadols retails at €5.32, a 33% hike, and a box of 60 Brufen tablets sells for €11.96, a 34% jump. Even fertility medication hasn't escaped these savage increases.
Fertility medication, an essential for many couples, has also been hit hard. A box of 30 Clomid 50mg tablets now retails at €39, a 19% increase. A box of seven 25mg Pleyris vials has increased from €57.90 to €78.90, a 36% jump.
Overall, the price increases on this list range from a few cents to tens of euros, with some medications seeing increases of over 200% within just 18 months. Not all of these increases can be justified by yearly inflation rates.
And this is the part most people miss... In 2023, there were price reductions for 66 medicines, including Septrin Forte, an antibiotic, and Anthisan, a cream to reduce itching. However, today, these medications have reverted to their previous, higher prices. For example, Septrin Forte, which had its price reduced by 20% in 2023, is now 29% more expensive than the negotiated price.
According to National Statistics Office data, medical services and medicines exhibited an annual inflation rate of 2.9%, which is relatively moderate. However, those in the field argue that overall inflation doesn't reflect what patients experience, as they often don't seek out cheaper alternatives.
A family doctor, speaking anonymously, explained that patients trust their doctors and pharmacists to provide the prescribed medication, regardless of cost. They added that while some doctors consider price sensitivity, others are influenced by incentives from importers, who promote their products to doctors.
Pharmacies, too, may have financial incentives to push certain over-the-counter medicines, leading patients to pay higher prices unless they are specifically prescribed or suggested cheaper alternatives.
A small market, big problems: A pharmaceutical importer, also speaking anonymously, attributed the issue to Malta's small market size and the impact of Brexit. Importing medicines from other EU countries has become more expensive due to the need for smaller batches and English translations for the Maltese market.
Importing from Ireland is an option, but prices are generally higher than in the UK, where the national health service's purchasing power helps stabilize prices. Malta has a Brexit exemption to import medicines from the UK, but this will expire at the end of 2026. Importers are urging the government to negotiate an extension to avoid unnecessary price hikes.
A ticking time bomb: Another concern is the introduction of higher registration fees for medicines and pharmaceutical operators by the Medicines Authority last October. Unless these increases are reversed, importers will have no choice but to pass on the costs to consumers. The impact of these new fees could be significant, especially for medicines used by a small number of patients, which tend to be the most expensive.
Importers are in talks with the authorities to find a less punitive fee structure, considering Malta's unique circumstances. They are optimistic about achieving progress, acknowledging that registration fees have remained untouched for many years.
A heavy burden on Maltese households: Stephen Spiteri, PN MP, highlighted the negative impact of these price hikes on consumers, especially pensioners. Health Minister Jo Etienne Abela countered that most of the medicines on the list are offered for free through the Pharmacy of Your Choice scheme. He also claimed that none of the 66 medicines with reduced prices in 2023 have seen increases.
However, a recent study by the Organisation for Economic Co-operation and Development (OECD) and the European Observatory on Health Systems and Policies revealed that Malta stands out within the EU for its unusually high individual spending on retail pharmaceuticals. Retail medicines accounted for 18% of Malta's total health expenditure in 2023, well above the EU average of 13%. On a per capita basis, spending reached €648, the second-highest in the bloc after Germany.
Despite the availability of free medicines, Maltese families are the second-highest spenders on medicines in the EU, placing a significant financial burden on households.
This issue raises important questions: Are these price hikes justified? Who is responsible for ensuring affordable healthcare? And how can we ensure that patients have access to the medications they need without breaking the bank? We invite you to share your thoughts and experiences in the comments below.
